chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Patient tested positive while admitted.  Been admitted since 11/18/21.Complex medical history including chronic atrial fibrillation, hypertension, DM2, esophagitis with gastritis, gastric cancer with gastric outlet obstruction, cervical myelopathy, pseudogout, osteopenia, aspiration pneumonitis, urinary retention, admitted with nausea and vomiting, found to have gastric cancer with outlet obstruction.  A facility was consulted to assist with goals of care, now providing comfort-focused care at end of life
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with booster on 11/25/21.  Lot # not documented.   Covid breakthrough infection with inpatient hospital stay.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Feeling cold, Haematemesis, Hypoaesthesia
Clinical narrative: As the vaccine was being injected, my arm immediately began going numb and I felt pins and needles going down my left arm. My left index finger and thumb were numb for over an hour after. I was monitored by the doctor on site and sent home around 11am. After arriving home, I vomited once and fell asleep. I woke up about every 2 hours very nauseous, vomited once each time, and fell back asleep. At 9pm, I woke up shivering and having a very hard time breathing because my teeth were chattering so quickly. I felt so cold and all I could think to do was take a hot shower. In a daze, I walked to the bathroom and started vomiting uncontrollably. I got in the shower and kept vomiting. Thankfully, I was able to breathe more easily at that point, yet kept vomiting. After about 1 hour of continual vomiting, I noticed blood in the vomit. I immediately notified my parents and we went to the ER around 10:30pm. In the ER, I kept vomiting constantly and the nurse took me back right away. I was given an IV and 3 bags of fluids over 4 hours. I kept vomiting even with the fluids. I was given Zofran through the IV but it didn't help and I kept vomiting. I was also given 1 other anti-nausea through my IV that started with an "A", but I don't remember the name. Then I was given more Zofran through the IV but still couldn't stop vomiting. Finally, I was given Compazine through the IV and I was able to stop vomiting for 30 minutes. This was all over the course of 4 hours. I was ultimately sent home after that because it was 3am and my dad was exhausted. Over the next two days, I slept constantly and was unable to stay awake for longer than 20 minutes. After those two days, I felt completely back to normal and like nothing happened.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Nausea, Paraesthesia, Somnolence, Vomiting
Clinical narrative: As the vaccine was being injected, my arm immediately began going numb and I felt pins and needles going down my left arm. My left index finger and thumb were numb for over an hour after. I was monitored by the doctor on site and sent home around 11am. After arriving home, I vomited once and fell asleep. I woke up about every 2 hours very nauseous, vomited once each time, and fell back asleep. At 9pm, I woke up shivering and having a very hard time breathing because my teeth were chattering so quickly. I felt so cold and all I could think to do was take a hot shower. In a daze, I walked to the bathroom and started vomiting uncontrollably. I got in the shower and kept vomiting. Thankfully, I was able to breathe more easily at that point, yet kept vomiting. After about 1 hour of continual vomiting, I noticed blood in the vomit. I immediately notified my parents and we went to the ER around 10:30pm. In the ER, I kept vomiting constantly and the nurse took me back right away. I was given an IV and 3 bags of fluids over 4 hours. I kept vomiting even with the fluids. I was given Zofran through the IV but it didn't help and I kept vomiting. I was also given 1 other anti-nausea through my IV that started with an "A", but I don't remember the name. Then I was given more Zofran through the IV but still couldn't stop vomiting. Finally, I was given Compazine through the IV and I was able to stop vomiting for 30 minutes. This was all over the course of 4 hours. I was ultimately sent home after that because it was 3am and my dad was exhausted. Over the next two days, I slept constantly and was unable to stay awake for longer than 20 minutes. After those two days, I felt completely back to normal and like nothing happened.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Admitted to unknown hospital on 10/13/2021-Patient was not interviewed for COVID.  No other info is available. Outcome is unknown
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Cardiac flutter, Chest discomfort, Chest pain, Condition aggravated
Clinical narrative: Beginning several days after vaccination, I had chest discomfort on the left side of my chest. Pain was moderate and came in waves. Accompanied by occasional shortness of breath, fluttering feeling in left chest, mild nausea. Began having sharp pain in left side below armpit, near rib cage.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Flank pain, Nausea, Pain
Clinical narrative: Beginning several days after vaccination, I had chest discomfort on the left side of my chest. Pain was moderate and came in waves. Accompanied by occasional shortness of breath, fluttering feeling in left chest, mild nausea. Began having sharp pain in left side below armpit, near rib cage.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Beginning several days after vaccination, I had chest discomfort on the left side of my chest. Pain was moderate and came in waves. Accompanied by occasional shortness of breath, fluttering feeling in left chest, mild nausea. Began having sharp pain in left side below armpit, near rib cage.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Exposure to SARS-CoV-2, Headache, Oropharyngeal pain
Clinical narrative: Pt was exposed by daughter she lives with.  She has symptoms of palpitations, headache, and sore throat.  She was admitted with acute hypoxic respiratory failure with atrial fibrillation with RVR.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Pt was exposed by daughter she lives with.  She has symptoms of palpitations, headache, and sore throat.  She was admitted with acute hypoxic respiratory failure with atrial fibrillation with RVR.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Pfizer-BioNTech 5-11yo formulation administered to a person over the age of 12 years. This was the patient's first dose of the COVID vaccine series.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given adult Pfizer vaccine at a pediatric dose of 0.2 ml intramuscularly. Incident was discovered at time of second dose when lot number used was not correct. Patient's father was contacted about the incorrect dose. No adverse effects were reported by the father. Patient intends to receive second dose as scheduled after 3 weeks.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid 19 infection confirmed by PCR on 12/13/2021
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Dyspnoea, Erythema, Incorrect route of product administration, Laboratory test
Clinical narrative: 5 minutes after my 2nd dose - I cannot breathe since it was a drive thru, I had to press the horn to ask for help and when people came up, they said my face was so red. Then I told them I can't breathe, and they went inside my car, and they gave me an EpiPen for my left leg and then I felt that I couldn't breathe again, and I grabbed the nurse's shirt because I felt that I did not have any oxygen and after that they gave another EpiPen I had seizure and blacked out. They called 911 and I had 4-5 seizures on the way to the hospital. The hospital did some CT scan, MRI, and some other tests and it was discovered that I have a trigger (which was the vaccine - because it hit my nerves) other than that I was perfectly healthy but after I went home, I had a seizure again and it still happens frequently up to this day. I take Keppra (1500 mg) and Gabapentin for nerve pain.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Magnetic resonance imaging, Neuralgia, Seizure
Clinical narrative: 5 minutes after my 2nd dose - I cannot breathe since it was a drive thru, I had to press the horn to ask for help and when people came up, they said my face was so red. Then I told them I can't breathe, and they went inside my car, and they gave me an EpiPen for my left leg and then I felt that I couldn't breathe again, and I grabbed the nurse's shirt because I felt that I did not have any oxygen and after that they gave another EpiPen I had seizure and blacked out. They called 911 and I had 4-5 seizures on the way to the hospital. The hospital did some CT scan, MRI, and some other tests and it was discovered that I have a trigger (which was the vaccine - because it hit my nerves) other than that I was perfectly healthy but after I went home, I had a seizure again and it still happens frequently up to this day. I take Keppra (1500 mg) and Gabapentin for nerve pain.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest pain, Cough, Dyspnoea, Pain
Clinical narrative: 56 yr old female with pmh of depression , anxiety , bipolar disorder presented to er c/o cough , sob and chest pain. she , works as a chef , denies any sick contacts . she tested positive for covid pneumonia . she reports her chest pain has been coming more frequently and more intensity and radiates to arm .
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 test positive
Clinical narrative: 56 yr old female with pmh of depression , anxiety , bipolar disorder presented to er c/o cough , sob and chest pain. she , works as a chef , denies any sick contacts . she tested positive for covid pneumonia . she reports her chest pain has been coming more frequently and more intensity and radiates to arm .
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Dizziness, Feeding disorder, Feeling abnormal
Clinical narrative: Shoulder had usual soreness but by 1:30am I also had pain in head, neck, spine and if you can imagine even in my fingers and toes! I couldn't eat anything, the smell of foods made sick to my stomach, I was dizzy and couldn't even sit up... was miserable. This is day 3 and I'm just starting to feel better. The same thing happened with my 2nd dose lot#ER8737 but more intense and was ill for a longer amount of days.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Neck pain, Pain in extremity, Sitting disability
Clinical narrative: Shoulder had usual soreness but by 1:30am I also had pain in head, neck, spine and if you can imagine even in my fingers and toes! I couldn't eat anything, the smell of foods made sick to my stomach, I was dizzy and couldn't even sit up... was miserable. This is day 3 and I'm just starting to feel better. The same thing happened with my 2nd dose lot#ER8737 but more intense and was ill for a longer amount of days.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Spinal pain
Clinical narrative: Shoulder had usual soreness but by 1:30am I also had pain in head, neck, spine and if you can imagine even in my fingers and toes! I couldn't eat anything, the smell of foods made sick to my stomach, I was dizzy and couldn't even sit up... was miserable. This is day 3 and I'm just starting to feel better. The same thing happened with my 2nd dose lot#ER8737 but more intense and was ill for a longer amount of days.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Injection site pain, Nausea
Clinical narrative: First: Headache, Pain at Injection site. Second: Fever for several hours at a time, shortness of breath, Nausea, Chills The second set of symptoms persistent off and on for 72 Hours and only started to get under control after experiencing them for more than 24 hrs.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: First: Headache, Pain at Injection site. Second: Fever for several hours at a time, shortness of breath, Nausea, Chills The second set of symptoms persistent off and on for 72 Hours and only started to get under control after experiencing them for more than 24 hrs.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Alanine aminotransferase increased, Alpha-1 antitrypsin deficiency, Ammonia normal, Anion gap
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Antimitochondrial antibody, Antinuclear antibody, Aspartate aminotransferase increased, Bilirubin conjugated increased, Biopsy liver
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood albumin decreased, Blood alkaline phosphatase increased, Blood bilirubin increased, Blood calcium, Blood chloride decreased
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood cholesterol normal, Blood creatinine increased, Blood glucose, Blood lactic acid increased, Blood potassium normal
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood sodium decreased, Blood triglycerides, Blood urea normal, Carbon dioxide decreased, Ceruloplasmin
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chills, Eye colour change, Full blood count normal, Gene mutation identification test positive, Glomerular filtration rate decreased
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Haematocrit normal, Haemoglobin normal, Hepatic steatosis, Hepatitis viral test, High density lipoprotein decreased
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: International normalised ratio increased, Lipase normal, Liver function test increased, Low density lipoprotein normal, Mean cell haemoglobin concentration decreased
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Nausea, Non-high-density lipoprotein cholesterol, Platelet count decreased, Portogram, Protein total decreased
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Prothrombin time, Smooth muscle antibody, Ultrasound abdomen normal, White blood cell count increased
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Autoimmune hepatitis, Biopsy muscle abnormal, Lipids increased, Metabolic disorder, Necrotising myositis
Clinical narrative: Patient is a 47 year old with PMHx significant for hypothyroidism, hypertension, depression/anxiety, and dyslipidemia who is being transferred from Medical Center for hepatology evaluation for liver failure.   In August she was told her eyes looked yellow so had labs done by her PCP that showed elevated LFTs. Her last LFTs taken prior to this were in February of this same year and were normal. She had abdominal ultrasound done in September that showed normal liver, bile ducts and gallbladder. She was referred to hepatology for further evaluation and extensive work-up was negative including hepatitis panel, AMA, ceruloplasmin, 1-antitrypsin, ANA, ASMA. However, she did test positive for 2 copies of HFE gene. She was referred to hematology but has not yet been evaluated by them.   On 11/10 patient presented to Medical Center with nausea, chills and abdominal discomfort. Labs showed significantly worsening LFTs; total bilirubin of 9.6, direct bilirubin 6.9, AST 552, ALT 493, AP 199, lipase wnl and CBC wnl. She had had a CTAP a few days prior that showed fatty infiltration of her liver but otherwise was unremarkable. Given significantly worsening LFTs she was admitted for further evaluation. She had an ultrasound that showed "Persistent nonspecific coarse, heterogeneous hepatic parenchyma and outer contour nodularity suggesting cirrhosis with new small  perihepatic free fluid" but otherwise unremarkable. She underwent MRCP on 11/11 that did not show any choledocholithiasis or intra-hepatic or extra-hepatic ductal dilation. She had liver biopsy on 11/12 and results are still pending. She was monitored at Medical Center until bed was available at Medical Center.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen Lymph mobile axillary, under clavicle on left and base of neck on left side all mobile and non tender
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 RNA
Clinical narrative: Hospital admission on 10/17/2021 with unknown discharge date and unknown outcome.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Decreased appetite, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Pt was exposed to COVID 3 days prior to admission and received outpatient monoclonal antibody treatment.  He presented to the hospital with fatigue, decreased appetite, and confusion.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, Blood potassium decreased, COVID-19, Colitis
Clinical narrative: Vaccine 1 - 7 days after shot mild diarrhea thought to be colitis flare-up.   Vaccine 2 - 7 days after shot moderate diarrhea, acute kidney failure from dehydration.  COVID positive.  Diagnosed COVID colitis. Vaccine 3 - 7 days after shot severe vomiting and diarrhea, acute kidney failure from dehydration. COVID negative.  Influenza negative.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Dehydration, Diarrhoea, Influenza virus test negative, SARS-CoV-2 test positive
Clinical narrative: Vaccine 1 - 7 days after shot mild diarrhea thought to be colitis flare-up.   Vaccine 2 - 7 days after shot moderate diarrhea, acute kidney failure from dehydration.  COVID positive.  Diagnosed COVID colitis. Vaccine 3 - 7 days after shot severe vomiting and diarrhea, acute kidney failure from dehydration. COVID negative.  Influenza negative.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Vaccine 1 - 7 days after shot mild diarrhea thought to be colitis flare-up.   Vaccine 2 - 7 days after shot moderate diarrhea, acute kidney failure from dehydration.  COVID positive.  Diagnosed COVID colitis. Vaccine 3 - 7 days after shot severe vomiting and diarrhea, acute kidney failure from dehydration. COVID negative.  Influenza negative.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Injection site pain, Injection site swelling
Clinical narrative: Pain and swelling at injection site, chills lasting more than 8 hours, headache, muscle soreness, dizziness.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Pain and swelling at injection site, chills lasting more than 8 hours, headache, muscle soreness, dizziness.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Balance disorder, Feeling abnormal, Gait disturbance, Posture abnormal
Clinical narrative: 7 hours post receiving COVID-19 booster vaccine, I was driving in car, pulled into parking spot and had sudden onset of floating sensation, head tilt to right and twisting of head / upper torso to right side.  No confusion, headache, vision changes, dizziness, perception of objects spinning, changes in breathing, cardiac symptoms, or other neurological symptoms.  As a physician, I actually was worried I was having a stroke.  Called for help from partner, a first responder.  Escorted inside. I was off balance and needed significant assistance to get upstairs.  Afebrile, HR, RR, BP within normal limits. A+Ox3.  Normal, facial symmetry.  Continued to have head tilt to right with feeling of falling to right side.  Lasted ~ 1.5 hours then changed to more of a typical positional vertigo which continued another couple hours until I fell asleep.  Next morning, feeling back to normal, aside from continued vertigo with rapid change to head position.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo, Vertigo positional
Clinical narrative: 7 hours post receiving COVID-19 booster vaccine, I was driving in car, pulled into parking spot and had sudden onset of floating sensation, head tilt to right and twisting of head / upper torso to right side.  No confusion, headache, vision changes, dizziness, perception of objects spinning, changes in breathing, cardiac symptoms, or other neurological symptoms.  As a physician, I actually was worried I was having a stroke.  Called for help from partner, a first responder.  Escorted inside. I was off balance and needed significant assistance to get upstairs.  Afebrile, HR, RR, BP within normal limits. A+Ox3.  Normal, facial symmetry.  Continued to have head tilt to right with feeling of falling to right side.  Lasted ~ 1.5 hours then changed to more of a typical positional vertigo which continued another couple hours until I fell asleep.  Next morning, feeling back to normal, aside from continued vertigo with rapid change to head position.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cardiac disorder, Myalgia
Clinical narrative: Received the Moderna covid booster vaccine. (Moderna was the original vaccine provider as well.) After booster I had illness symptoms of joint and muscle achiness not experienced originally, but that was not particularly concerning. I also could feel some sort of differences the way my heart normally behaves. Typically I am not consciously aware of my heartbeat but assume it remains operational. However since the booster I can "feel" it somewhat regularly and it seems to be beating slightly differently. It's somewhat subtle but persistent. The joint and muscle achiness have gone away, but the heart differences remain so far, so as a precaution I haven't resumed normal physical exercise/activity yet.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Nausea, Pyrexia
Clinical narrative: Chills, fever, joint pain in all joints, full body muscle aches, nausea, vomiting.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Chills, fever, joint pain in all joints, full body muscle aches, nausea, vomiting.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth, Urticaria
Clinical narrative: Received the booster Moderna vaccine on 12/10/2021; on 12/12/2021 noticed a red "Welt" around the injection site, warm to the touch. This area continued to get bigger over the next two days. This morning the red area (roughly oval shaped) measures 5in by 3in. It is still warm to the touch and is slightly swollen and itchy. Managing with OTC ibuprofen, ice and topical steroids (hydrocortisone) and waiting for resolution.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Herpes zoster, Mass, Pain in extremity, Pruritus
Clinical narrative: Had booster vaccine on 12/2/2021.  Arm was sore, red, itchy and had a large lump for about 1 week.  Approximately 8 days after booster vaccination (12/10/2021) was diagnosed with Shingles.  I have never had shingles before.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Had booster vaccine on 12/2/2021.  Arm was sore, red, itchy and had a large lump for about 1 week.  Approximately 8 days after booster vaccination (12/10/2021) was diagnosed with Shingles.  I have never had shingles before.
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB, VARCEL
Symptoms: Erythema, Injection site urticaria, Irritability, Peripheral swelling
Clinical narrative: as soon as the Pentacel was given  patient immediately turned red, became irritable unconsolably,  then few minutes later his right leg became swollen  then left started to swell as well and he started to develop hives on his arm at the sight of injection
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 RNA
Clinical narrative: Admitted to hospital on 10/28/2021 unknown discharge or outcome
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death
Clinical narrative: DEATH.  - Had Moderna booster shot on 11/17 12:00pm  - We did not hear from him  on 11/18... We believe he passed on 11/18. - Police found him dead on 11/19 8:31 floor next to bed. Death certificate says "cardiac arrest" has reason for death.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Lot # 053E21A was administered outside the 30-day Use by Date.  A case was opened with Moderna ID Case ID CEA-1261.  "The vaccine administered maintained the activity necessary to protect against the SARS-CoV-2 (Covid-19) virus at time of administration."
Age: 38.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Condition aggravated, Epstein-Barr virus infection reactivation, Fatigue, Lymph node pain, Lymphadenopathy
Clinical narrative: I had swollen lymph nodes under my left arm pit that were sore.  This lasted about 3-5 days. I had extreme fatigue during this time as well. No fevers.  I still have reactivated EBV symptoms, and it seems ongoing. This was present before my booster & flu shot, but may have started around my original vaccinations in March 2021, or possibly prior to that as well.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Throat irritation
Clinical narrative: PT SITTING IN OBSERVATION AREA, POST INJECTION AND COMPLAINT OF SCRATCHY THROAT AND HEADACHE ABOUT 15 MINUTES INTO MONITORING. PT DENIED ANY CHEST PAIN, OR SOB, PT WHEELCHAIRED TO URGENT CARE BY RN AND SECURITY.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cardiomegaly, Chest X-ray abnormal
Clinical narrative: Pt arrives pov with sob. Pt has no chest pain. tp has home o2 but has not needed to wear it. Pt then says he is here for sob and wasnt using his home O2 he has for copd. Pt has had J and j vaccine a while back pt is a former smoker. Pt has Nausea nd vomiting and has not been eating well. Pt denies fevers. Pt has lost sense of smell and taste. Pt had a cough that has improved, he says he had a cough on Friday.  Associated Symptoms: nausea, shortness of breath, vomiting 69-year-old male with history of diabetes mellitus, hypertension, former smoker with COPD, acute kidney injury January 2020 attributed to acute tubular necrosis with recovery and baseline creatinine around 1.2-1.3 mg/dL, presents to the hospital with cough, wheezing with phlegm (does not know the color), poor appetite and oral intake.  Found to be COVID-19 positive, patient is vaccinated with Johnson & Johnson (does not know when) and was found to have bilateral infiltrates on chest x-ray.  No fever or chills reported, no nausea or vomiting, no diarrhea.  No joint pains or rash.  Patient is saturating 85% on room air and placed on supplemental oxygen and saturating 95% on 2 L nasal cannula.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dyspnoea, Fibrin D dimer increased, Hypophagia
Clinical narrative: Pt arrives pov with sob. Pt has no chest pain. tp has home o2 but has not needed to wear it. Pt then says he is here for sob and wasnt using his home O2 he has for copd. Pt has had J and j vaccine a while back pt is a former smoker. Pt has Nausea nd vomiting and has not been eating well. Pt denies fevers. Pt has lost sense of smell and taste. Pt had a cough that has improved, he says he had a cough on Friday.  Associated Symptoms: nausea, shortness of breath, vomiting 69-year-old male with history of diabetes mellitus, hypertension, former smoker with COPD, acute kidney injury January 2020 attributed to acute tubular necrosis with recovery and baseline creatinine around 1.2-1.3 mg/dL, presents to the hospital with cough, wheezing with phlegm (does not know the color), poor appetite and oral intake.  Found to be COVID-19 positive, patient is vaccinated with Johnson & Johnson (does not know when) and was found to have bilateral infiltrates on chest x-ray.  No fever or chills reported, no nausea or vomiting, no diarrhea.  No joint pains or rash.  Patient is saturating 85% on room air and placed on supplemental oxygen and saturating 95% on 2 L nasal cannula.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Lung infiltration, Lung opacity, Nausea, Pneumonia, Productive cough
Clinical narrative: Pt arrives pov with sob. Pt has no chest pain. tp has home o2 but has not needed to wear it. Pt then says he is here for sob and wasnt using his home O2 he has for copd. Pt has had J and j vaccine a while back pt is a former smoker. Pt has Nausea nd vomiting and has not been eating well. Pt denies fevers. Pt has lost sense of smell and taste. Pt had a cough that has improved, he says he had a cough on Friday.  Associated Symptoms: nausea, shortness of breath, vomiting 69-year-old male with history of diabetes mellitus, hypertension, former smoker with COPD, acute kidney injury January 2020 attributed to acute tubular necrosis with recovery and baseline creatinine around 1.2-1.3 mg/dL, presents to the hospital with cough, wheezing with phlegm (does not know the color), poor appetite and oral intake.  Found to be COVID-19 positive, patient is vaccinated with Johnson & Johnson (does not know when) and was found to have bilateral infiltrates on chest x-ray.  No fever or chills reported, no nausea or vomiting, no diarrhea.  No joint pains or rash.  Patient is saturating 85% on room air and placed on supplemental oxygen and saturating 95% on 2 L nasal cannula.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting, Wheezing
Clinical narrative: Pt arrives pov with sob. Pt has no chest pain. tp has home o2 but has not needed to wear it. Pt then says he is here for sob and wasnt using his home O2 he has for copd. Pt has had J and j vaccine a while back pt is a former smoker. Pt has Nausea nd vomiting and has not been eating well. Pt denies fevers. Pt has lost sense of smell and taste. Pt had a cough that has improved, he says he had a cough on Friday.  Associated Symptoms: nausea, shortness of breath, vomiting 69-year-old male with history of diabetes mellitus, hypertension, former smoker with COPD, acute kidney injury January 2020 attributed to acute tubular necrosis with recovery and baseline creatinine around 1.2-1.3 mg/dL, presents to the hospital with cough, wheezing with phlegm (does not know the color), poor appetite and oral intake.  Found to be COVID-19 positive, patient is vaccinated with Johnson & Johnson (does not know when) and was found to have bilateral infiltrates on chest x-ray.  No fever or chills reported, no nausea or vomiting, no diarrhea.  No joint pains or rash.  Patient is saturating 85% on room air and placed on supplemental oxygen and saturating 95% on 2 L nasal cannula.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Lot # 053E21A was administered outside the 30-day Use by Date.   "The vaccine administered maintained the activity necessary to protect against the SARS-CoV-2 (Covid-19) virus at time of administration."